Precipio Gross Margin 2012-2026 | PRPO
Current and historical gross margin for Precipio (PRPO) over the last 10 years. The current gross profit margin for Precipio as of March 31, 2026 is %.
| Precipio Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $0.03B | $0.01B | 40.74% |
| 2025-12-31 | $0.03B | $0.01B | 40.00% |
| 2025-09-30 | $0.02B | $0.01B | 43.48% |
| 2025-06-30 | $0.02B | $0.01B | 42.86% |
| 2025-03-31 | $0.02B | $0.01B | 47.37% |
| 2024-12-31 | $0.02B | $0.01B | 47.06% |
| 2024-09-30 | $0.02B | $0.01B | 43.75% |
| 2024-06-30 | $0.02B | $0.01B | 43.75% |
| 2024-03-31 | $0.02B | $0.01B | 37.50% |
| 2023-12-31 | $0.02B | $0.01B | 37.50% |
| 2023-09-30 | $0.01B | $0.01B | 35.71% |
| 2023-06-30 | $0.01B | $0.00B | 27.27% |
| 2023-03-31 | $0.01B | $0.00B | 33.33% |
| 2022-12-31 | $0.01B | $0.00B | 37.50% |
| 2022-09-30 | $0.01B | $0.00B | 37.50% |
| 2022-06-30 | $0.01B | $0.00B | 50.00% |
| 2022-03-31 | $0.01B | $0.00B | 50.00% |
| 2021-12-31 | $0.01B | $0.00B | 37.50% |
| 2021-09-30 | $0.01B | $0.00B | 25.00% |
| 2021-06-30 | $0.01B | $0.00B | 12.50% |
| 2021-03-31 | $0.01B | 0 | 0.00% |
| 2020-12-31 | $0.01B | 0 | 0.00% |
| 2020-09-30 | $0.01B | 0 | 0.00% |
| 2020-06-30 | $0.00B | 0 | 0.00% |
| 2020-03-31 | $0.00B | 0 | 0.00% |
| 2019-12-31 | $0.00B | 0 | 0.00% |
| 2019-09-30 | $0.00B | 0 | 0.00% |
| 2019-06-30 | $0.00B | 0 | 0.00% |
| 2019-03-31 | $0.00B | 0 | 0.00% |
| 2018-12-31 | $0.00B | 0 | 0.00% |
| 2018-09-30 | $0.00B | 0 | 0.00% |
| 2018-06-30 | $0.00B | 0 | 0.00% |
| 2018-03-31 | $0.00B | 0 | 0.00% |
| 2017-12-31 | $0.00B | 0 | 0.00% |
| 2017-09-30 | $0.00B | $0.00B | 100.00% |
| 2017-06-30 | $0.00B | $0.00B | 100.00% |
| 2017-03-31 | $0.00B | $0.00B | 50.00% |
| 2016-12-31 | $0.00B | $0.00B | 50.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-06-30 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-12-31 | $0.00B | 0 | 0.00% |
| 2015-09-30 | $-0.02B | $-0.01B | 53.33% |
| 2015-06-30 | $-0.01B | $-0.01B | 54.55% |
| 2015-03-31 | $0.00B | $0.00B | 100.00% |
| 2014-12-31 | $0.00B | $0.00B | -200.00% |
| 2014-09-30 | $0.02B | $0.01B | 34.78% |
| 2014-06-30 | $0.03B | $0.01B | 30.77% |
| 2014-03-31 | $0.03B | $0.01B | 34.62% |
| 2013-12-31 | $0.03B | $0.01B | 37.04% |
| 2013-09-30 | $0.03B | $0.01B | 35.71% |
| 2013-06-30 | $0.03B | $0.01B | 41.38% |
| 2013-03-31 | $0.03B | $0.01B | 45.16% |
| 2012-12-31 | $0.03B | $0.01B | 45.16% |
| 2012-09-30 | $0.03B | $0.02B | 51.52% |
| 2012-06-30 | $0.03B | $0.02B | 51.52% |
| 2012-03-31 | $0.03B | $0.02B | 53.13% |
| 2011-12-31 | $0.03B | $0.02B | 56.25% |
| 2011-09-30 | $0.03B | $0.02B | 53.57% |
| 2011-06-30 | $0.02B | $0.01B | 54.17% |
| 2011-03-31 | $0.02B | $0.01B | 47.62% |
| 2010-12-31 | $0.02B | $0.01B | 47.37% |
| 2010-09-30 | $0.02B | $0.01B | 47.62% |
| 2010-06-30 | $0.02B | $0.01B | 50.00% |
| 2010-03-31 | $0.02B | $0.01B | 54.55% |
| 2009-12-31 | $0.02B | $0.01B | 54.55% |
| 2009-09-30 | $0.02B | $0.01B | 57.14% |
| 2009-06-30 | $0.02B | $0.01B | 57.14% |
| 2009-03-31 | $0.02B | $0.01B | 59.09% |
| 2008-12-31 | $0.02B | $0.01B | 60.87% |
| 2008-09-30 | $0.02B | $0.02B | 62.50% |
| 2008-06-30 | $0.02B | $0.02B | 62.50% |
| 2008-03-31 | $0.02B | $0.01B | 58.33% |
| 2007-12-31 | $0.02B | $0.01B | 56.52% |
| 2007-09-30 | $0.02B | $0.01B | 54.55% |
| 2007-06-30 | $0.02B | $0.01B | 50.00% |
| 2007-03-31 | $0.02B | $0.01B | 50.00% |
| 2006-12-31 | $0.02B | $0.01B | 47.83% |
| 2006-09-30 | $0.02B | $0.01B | 45.45% |
| 2006-06-30 | $0.02B | $0.01B | 45.83% |
| 2006-03-31 | $0.03B | $0.01B | 44.00% |
| 2005-12-31 | $0.03B | $0.01B | 42.31% |
| 2005-09-30 | $0.03B | $0.01B | 37.93% |
| 2005-06-30 | $0.03B | $0.01B | 30.00% |
| 2005-03-31 | $0.03B | $0.01B | 28.13% |
| 2004-12-31 | $0.03B | $0.01B | 26.47% |
| 2004-09-30 | $0.04B | $0.01B | 28.57% |
| 2004-06-30 | $0.04B | $0.01B | 28.57% |
| 2004-03-31 | $0.03B | $0.01B | 29.41% |
| 2003-12-31 | $0.04B | $0.01B | 31.43% |
| 2003-09-30 | $0.04B | $0.01B | 34.29% |
| 2003-06-30 | $0.04B | $0.02B | 41.67% |
| 2003-03-31 | $0.04B | $0.02B | 45.95% |
| 2002-12-31 | $0.04B | $0.02B | 48.65% |
| 2002-09-30 | $0.04B | $0.02B | 51.28% |
| 2002-06-30 | $0.04B | $0.02B | 55.00% |
| 2002-03-31 | $0.04B | $0.02B | 53.66% |
| 2001-12-31 | $0.04B | $0.02B | 53.85% |
| 2001-09-30 | $0.04B | $0.02B | 54.29% |
| 2001-06-30 | $0.03B | $0.02B | 51.61% |
| 2001-03-31 | $0.03B | $0.01B | 51.85% |
| 2000-12-31 | $0.03B | $0.01B | 50.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.049B | $0.024B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |